Latest Headlines

  1. Volta Labs Expands Presence In The Nordic Region With Callisto Placement At Norway's Norwegian Sequencing Centre, University Of Oslo 7/3/2025

    Volta Labs, Inc., a leading genomics applications company, announced today the expansion of its commercial presence in Europe with the installation of its Callisto Sample Prep System™ at the Norwegian Sequencing Centre (NSC) in Oslo, Norway.

  2. Thermo Fisher's NGS Assay Receives FDA Approval As A Companion Diagnostic For ZEGFROVY And For Tumor Profiling 7/3/2025

    Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) has approved the Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for Dizal’s ZEGFROVY (sunvozertinib) and in tumor profiling.

  3. Spartanburg Regional Healthcare System (SRHS) Selects AccessDx Laboratory As Pharmacogenomics (PGx) Program Partner 7/2/2025

    Spartanburg Regional Healthcare System (SRHS) has selected AccessDx Laboratory as its partner to power a comprehensive pharmacogenomics (PGx) program.

  4. Diasorin Submits The LIAISON NES Point-Of-Care Molecular Diagnostics System And 4-Plex Respiratory Panel To The FDA For 510(k) Clearance And CLIA Waiver 7/2/2025

    Diasorin announces the submission of a 510(k) premarket notification and CLIA waiver application to the U.S. Food and Drug Administration (FDA) for its LIAISON NES, a next-generation molecular POC testing platform.

  5. VIAVI Introduces Colocation Capability At VALOR Lab-As-A-Service Testing Facility 7/2/2025

    VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced that it has added colocation capability to its VIAVI Automated Lab-as-a-Service for Open RAN (VALOR™) facility to address the increased demand for comprehensive testing from Open RAN customers.

  6. Adaptive Biotechnologies And Flatiron Health Announce Integration Of clonoSEQ®: MRD Testing Into OncoEMR® 7/1/2025
  7. Seegene Launches STAgora™, A New Platform For Infectious Disease Analytics 7/1/2025

    Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a next-generation platform for infectious disease analytics.

  8. Diatron Launches P780, The Most Advanced Clinical Chemistry System! 7/1/2025

    Diatron—a trusted partner in developing, manufacturing and marketing hematology and clinical chemistry analyzers and associated reagents for human medical and veterinary use—has launched its new clinical chemistry analyzer, the P780.

  9. PathAI Receives FDA Clearance For AISight® Dx Platform For Primary Diagnosis 6/30/2025

    PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight® Dx*—its digital pathology image management system—for use in primary diagnosis in clinical settings.

  10. RetinalGenix Technologies Contracts With LabCorp To Support DNA/GPS Platform For Advanced Genetic And Retinal Health Screening 6/27/2025

    RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurposed drug development for early detection and treatment of eye and systemic diseases, has entered into an agreement with LabCorp, one of the nation’s largest laboratory services organizations, to support the rollout of the RetinalGenix DNA/RNA/GPS Pharmaco-Genetic Mapping™ platform.